School Districts Planning Vaccine Clinics for Eligible Kids

News

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Connecticut education and health officials are working together to organize clinics that would give children ages 12 to 15 access to Pfizer’s COVID-19 vaccine as soon as the federal government gives final approval for its emergency use in that age group.

Clinics have been held at schools in more than 30 districts for 16- to 18-year-olds and others are being planned that could be expanded to vaccinate younger students, Peter Yazbak, a spokesperson for the Department of Education, said Tuesday.

“Having clinics on site at the schools makes access easy for students and eliminates some of the logistical barriers that might be there for them,” he said.

Yazbak said the decisions on how to offer the vaccine are being made at the district level with local health departments. He said some may opt for bus trips to mass vaccination sites or work with local providers to get the vaccine into the arms of 12- to 15-year-olds, with parental permission, as soon as that age group is eligible.

“The school-run efforts are really the most effective, because they are right there at the grassroots,” he said. “They have the most communication with the families and providers.”

About 49% of the state’s 16- to 17-year-olds had already received their first dose of the vaccine as of Sunday, he said.

The official sign-off on the vaccine’s use in the 12-15 age group will not occur until at least Wednesday, when a Centers for Disease Control and Prevention committee meets.

Yazbak and the governor’s office said they expect many of the vaccinations will be offered on weekends, when parents can more easily accompany their children.

The governor’s office said providers requested and received more doses of the Pfizer vaccine this week in anticipation of the age expansion.

Gov. Ned Lamont said Monday he does not plan to require that teens get the vaccine as a condition of returning to the classroom next fall.

Products You May Like

Articles You May Like

Engineering nanobodies to fight against the SARS-CoV-2 virus
COVID May Cause Long-Term Brain Loss, Study Says
China has administered more than 1 billion doses of its Covid-19 vaccines
What People With Asthma Need to Know About Face Masks During the COVID-19 Pandemic
Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Leave a Reply

Your email address will not be published. Required fields are marked *